Capítulo 4: 

1 Polonius—Shakespeare W. The Tragedy of Hamlet, Prince of Denmark. https://en.wikipedia.org/wiki/Hamlet

2 Harris GT et al. Prospective replication of the Violence Risk Appraisal Guide in predicting violent recidivism among forensic patients. Law and Human Behavior 26.4 (2002): 377–394. PubMed ID: 12182529. http://www.ncbi.nlm.nih.gov/pubmed/12182529

3 Rogers R. The uncritical acceptance of risk assessment in forensic practice. Law and Human Behavior 24.5 (2000): 595–605. http://psycnet.apa.org/journals/lhb/24/5/595/

4 Kumar S et al. Application of risk assessment for violence methods to general adult psychiatry: a selective literature review. Australian and New Zealand Journal of Psychiatry 39.5 (2005): 328–335. http://www.tandfonline.com/doi/abs/10.1080/j.1440–1614.2005.01579.x

5 Hartvig P et al. Brief checklists for assessing violence risk among patients discharged from acute psychiatric facilities: a preliminary study. Nordic Journal of Psychiatry 60.3 (2006): 243–248. http://www.tandfonline.com/doi/abs/10.1080/08039480600780532

6 Carroll A. Are violence risk assessment tools clinically useful? Australian and New Zealand Journal of Psychiatry 41.4 (2007): 301–307. http://www.tandfonline.com/doi/abs/10.1080/00048670701213237

7 Lincoln TM. Relevant dimensions of delusions: continuing the continuum versus category debate. Schizophrenia Research93.1 (2007): 211–220. http://www.sciencedirect.com/science/article/pii/S0920996407001077

8 Sims A. Symptoms in the mind. London: Saunders; 1995. https://books.google.co.uk/books/about/Symptoms_in_the_Mind.html?id=DbNrAAAAMAAJ&redir_esc=y

9 The Economist. Living a second life. The Economist 28 September 2006. http://www.economist.com/business/displaystory.cfm?story_id=7963538

10 Colman EAM. Squibb academic lecture: Shakespeare and DSM-III. Australasian Psychiatry 20.1 (1986): 30–36. http://informahealthcare.com/doi/pdf/10.3109/00048678609158862

11 Sonnenschein M et al. Evidence that impaired sleep recovery may complicate burnout improvement independently of depressive mood. Journal of Psychosomatic Research 62.4 (2007): 487–494. http://www.sciencedirect.com/science/article/pii/S0022399906005137

12 Dennis AM et al. Expressed emotion and burnout: the experience of staff caring for men with learning disability and psychosis in a medium secure setting. Journal of Psychiatric and Mental Health Nursing 14.3 (2007): 267–276. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2850.2007.01073.x/full

13 Glasberg J et al. Prevalence of the burnout syndrome among Brazilian medical oncologists. Revista da Associação Médica Brasileira 53.1 (2007): 85–89. http://www.scielo.br/scielo.php?pid=S0104-42302007000100026&script=sci_arttext&tlng=es

14 Embriac N et al. High level of burnout in intensivists: prevalence and associated factors. American Journal of Respiratory and Critical Care Medicine 175.7 (2007): 686–692. PubMed ID: 17234905. http://www.atsjournals.org/doi/abs/10.1164/rccm.200608-1184OC

15 Böhle A et al. Burn-out of urologists in the county of Schleswig-Holstein, Germany: a comparison of hospital and private practice urologists. The Journal of Urology 165.4 (2001): 1158–1161. http://www.sciencedirect.com/science/article/pii/S0022534705664543

16 Glasberg AL et al. Burnout and ’stress of conscience’among healthcare personnel. Journal of Advanced Nursing 57.4 (2007): 392–403. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2648.2007.04111.x/pdf

17 Morse G et al. Burnout in mental health services: a review of the problem and its remediation. Administration and Policy in Mental Health and Mental Health Services Research 39.5 (2012): 341–352. http://link.springer.com/article/10.1007/s10488-011-0352-1

18 Moulden HM et al. Vicarious traumatization: the impact on therapists who work with sexual offenders. Trauma Violence Abuse 8.1 (2007): 67–83. PubMed ID: 17204600. http://www.ncbi.nlm.nih.gov/pubmed/17204600

19 Yousefy AR et al. Job burnout in psychiatric and medical nurses in Isfahan, Islamic Republic of Iran. WHO; 2006. http://apps.who.int/iris/handle/10665/117134

20 Dahlin ME et al. Burnout and psychiatric morbidity among medical students entering clinical training: a three year prospective questionnaire and interview-based study. BMC Medical Education 7.1 (2007): 6. http://www.biomedcentral.com/1472-6920/7/6

21 Breitbart W et al. Reframing hope: meaning-centered care for patients near the end of life. Journal of Palliative Medicine 6.6 (2003): 979–988. http://online.liebertpub.com/doi/pdf/10.1089/109662103322654901

22 Gorter, RC et al. A career counseling program for dentists: effects on burnout. Patient Education and Counseling 43.1 (2001): 23–30. http://www.sciencedirect.com/science/article/pii/S0738399100001415

23 Murdoch JM et al. ‘Stress-busting’ groups for consultant psychiatrists. The Psychiatrist 31.4 (2007): 128–131. http://pb.rcpsych.org/content/31/4/128.short

24 Browne G et al. Economic evaluations of community-based care: lessons from twelve studies in Ontario. Journal of Evaluation in Clinical Practice 5.4 (1999): 367–385. http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2753.1999.00191.x/abstract

25 Rosenheck RA et al. Cost-effectiveness of intensive psychiatric community care for high users of inpatient services. Archives of General Psychiatry 55.5 (1998): 459–466. http://archneur.jamanetwork.com/article.aspx?articleid=203887

26 Maden A et al. Offending in psychiatric patients after discharge from medium secure units: prospective national cohort study. BMJ 328.7455 (2004): 1534. http://www.bmj.com/content/328/7455/1534?variant=short

27 Dieterich M, Irving CB, Park B, Marshall M. Intensive case management for severe mental illness. Cochrane Database of Systematic Reviews 2010, Issue 10. http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD007906.pub2

28 Marshall M et al. Assertive community treatment for people with severe mental disorders. The Cochrane Library (2011). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001089/pdf/

29 Petersen L et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 331.7517 (2005): 602. http://www.bmj.com/content/331/7517/602.short

30 Hellerstein DJ et al. Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly 72.4 (2001): 291–306. http://link.springer.com/article/10.1023/A:1010385114289

31 Jeffery D et al. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2 (2000):CD001088. http://www.ncbi.nlm.nih.gov/pubmed/11034697

32 Wiersma D et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin 24.1 (1998):75. http://psycnet.apa.org/journals/szb/24/1/75/

33 Mueser KT et al. Schizophrenia. The Lancet 2004;363:2063–2072. http://www.ncbi.nlm.nih.gov/pubmed/15207959

34 van Os J et al. Schizophrenia. The Lancet 374 (2009): 635–645. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60995-8/abstract

35 Kramlinger KG et al. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatrica Scandinavica 79.4 (1989): 378–385. http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.1989.tb10273.x/abstract

36 Miller DS et al. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Journal of Clinical Psychiatry 62.12 (2001): 975–980. http://www.ncbi.nlm.nih.gov/pubmed/11780879

37 Tohen M et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry 2002;59:62–69. http://archpsyc.jamanetwork.com/article.aspx?articleid=205956

38 Sachs GS et al. The expert consensus guideline series: medication treatment of bipolar disorder. Postgraduate Medicine 1 (2000): 1–104. http://files.getaufc.webnode.com.br/200000231-e511ee60c3/Bipolar_2000.pdf

39 Compton MT et al. The treatment of bipolar depression. Journal of Clinical Psychiatry 61 (2000):57–67. http://psycnet.apa.org/psycinfo/2000-15744-009

40 Mukherjee S et al. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. American Journal of Psychiatry 151.2 (1994): 169–176. http://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.151.2.169

41 Sarris J et al. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. The Journal of Clinical Psychiatry 73.1 (2012): 81–86. http://europepmc.org/abstract/med/21903025

42 Wiersma D et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin 24.1 (1998): 75. http://psycnet.apa.org/journals/szb/24/1/75/

43 Mueser KT et al. Schizophrenia. The Lancet 363 (2004):2063–2072. PubMed ID: 15207959. http://www.ncbi.nlm.nih.gov/pubmed/15207959

44 ‘Schizophrenia’ term ought to be abolished” http://www.bio-medicine.org/medicine-news/-u2018Schizophrenia-u2019-term-ought-to-be-abolishd-14857-1/

45 Stefansson H et al. Neuregulin I and susceptibilityto schizophrenia. American Journal of Human Genetics 71 (2002):877–892. http://www.ncbi.nlm.nih.gov/pubmed/12145742

46 Straub RE et al. Genetic variation in the 6p22 gene DTNBPI, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics 71 (2002):337–348. http://www.ncbi.nlm.nih.gov/pubmed/12098102

47 Caspi A et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry 57.10 (2005): 1117–1127. PubMed ID: 15866551. http://www.ncbi.nlm.nih.gov/pubmed/15866551

48 Murray R. New ways of thinking about and treating psychosis. Keynote lecture. Progress in Neurology and Psychiatry 8.8 (2004): 20–26. http://www.progressnp.com/

49 Andreasson S et al. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. The Lancet 2 (1987):1483–1486 http://www.ncbi.nlm.nih.gov/pubmed/2892048

50 Arseneault L et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325 (2002):1212–1213 http://www.ncbi.nlm.nih.gov/pubmed/12446537

51 Jones P et al. Child development risk factors for adult schizophrenia in the British 1946 cohort. The Lancet 344 (1994): 1398–1402 http://www.ncbi.nlm.nih.gov/pubmed/7968076

52 Jones P et al. Schizophrenia as a long-term outcome of pregnancy, delivery and perinatal complications: a 28-year follow-up of the 1966 north Finland general population cohort. American Journal of Psychiatry 155.3 (1998):355–364 http://www.ncbi.nlm.nih.gov/pubmed/9501745

53 Boos HB et al. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry64.3 (2007): 297–304. PubMed ID: 17339518. http://www.ncbi.nlm.nih.gov/pubmed/17339518

54 Puri BK et al. Revision notes in psychiatry, 2nd ed. London: Arnold; 2002, 377–378. ISBN 0340761318 http://www.arnoldpublishers.com/

55 Dorph-Petersen KA et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30.9 (2005): 1649–1661. PubMed ID: 15756305. http://www.ncbi.nlm.nih.gov/pubmed/15756305

56 Murray RM et al. A neurodevelopmental approach to the classification to schizophrenia. Schizophrenia Bulletin 18 (1992): 319–332. http://sun.bma.org.uk/ovidweb_T/ovidweb.cgi

57 Murray RM. New ways of thinking about and treating psychosis. Keynote lecture. Progress in Neurology and Psychiatry 8.8 (2004): 20–26 http://www.progressnp.com

58 Marshall M et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 62.9 (2005): 975–983. http://archneur.jamanetwork.com/article.aspx?articleid=1108403

59 Cant B. Exploring the implications for health professionals of men coming out as gay in healthcare settings. Health & Social Care in the Community 14.1 (2006): 9–16. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2524.2005.00583.x/full

60 Awad AG et al. The burden of schizophrenia on caregivers. Pharmacoeconomics 26.2 (2008): 149–162. http://link.springer.com/article/10.2165/00019053-200826020-00005

61 Bressi C et al. Systemic family therapy in schizophrenia: a randomized clinical trial of effectiveness. Psychotherapy and Psychosomatics 77.1 (2008): 43–49. http://www.karger.com/Article/FullText/110059

62 Morgan VA et al. Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Australian and New Zealand Journal of Psychiatry 42.1 (2008): 74–82. http://www.ncbi.nlm.nih.gov/pubmed/18058447

63 Amos AJ. A review of spin and bias use in the early intervention in psychosis literature. The Primary Care Companion for CNS Disorders 16.1 (2014). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048144/

64 Bagnall A-M et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technology Assessment37.13 (2003): 1–193. http://www.ncbi.nlm.nih.gov/pubmed/12925268

65 Davis JM et al. A meta-analysis of the efficacy of second generation antipsychotics. Archives of General Psychiatry 60 (2003):553–564. http://www.ncbi.nlm.nih.gov/pubmed/12796218

66 Leucht S et al. Relapse prevention in schizophrenia with new-generation antipsychotic: a systematic review and exploratory meta-analysis of randomized controlled trials. American Journal of Psychiatry 160 (2003):1209–1222. PubMed ID: 12832232 http://www.ncbi.nlm.nih.gov/pubmed/12832232

67 Taylor M et al. ‘Do unto others as…’--which treatments do psychiatrists prefer? Scottish Medical Journal 52.1 (2007):17–19. PubMed ID: 17373419 http://www.ncbi.nlm.nih.gov/pubmed/17373419

68 Burns T et al. Switching antipsychotic medications: general recommendations and switching to amisulpride. Current Medical Research and Opinion 18.4 (2002): 201–208. PubMed ID: 12201620. http://www.ncbi.nlm.nih.gov/pubmed/12201620

69 Suzuki T et al. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. The International Journal of Neuropsychopharmacology 7.02 (2004): 133–142. http://journals.cambridge.org/abstract_S1461145703004012

70 Chan J et al. Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence. Journal of Psychopharmacology 21.6 (2007): 657–664. PubMed ID: 17092976. http://www.ncbi.nlm.nih.gov/pubmed/17092976

71 Arvanitis LA et al. Multiple fixed doses of “Seroquel”(quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biological Psychiatry 42.4 (1997): 233–246. http://www.ncbi.nlm.nih.gov/pubmed/9270900

72 Volavka J et al. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of Clinical Psychiatry 2004; 65:57–61. http://www.ncbi.nlm.nih.gov/pubmed/14744169

73 Costa AM et al. A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. Journal of Psychopharmacology 21.2 (2007): 161–170. PubMed ID: 17329296. http://www.ncbi.nlm.nih.gov/pubmed/17329296

74 Holtmann M et al. Risperidone-associated ejaculatory and urinary dysfunction in male adolescents. Journal of Child and Adolescent Psychopharmacology 13.1 (2003): 107–109. PubMed ID: 12804132 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=12804132&from=cqsr

75 Compton MT. Risperidone-induced ejaculatory disturbances. Psychiatric Services 53.3 (2002):347. http://ps.psychiatryonline.org/cgi/content/full/53/3/347

76 Rosenberg KP et al. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. Journal of Sex & Marital Therapy 29.4 (2003):289–296. PubMed ID: 14504017. http://www.ncbi.nlm.nih.gov/pubmed/=1450401

77 Keller R et al. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurological Sciences 23.5 (2002): 233–235. PubMed ID: 12522680. http://www.ncbi.nlm.nih.gov/pubmed/12522680

78 Taylor DM et al. Atypical antipsychotics and weight gain- a systematic review. Acta Psychiatrica Scandinavica 101 (2000):416–432 http://www.ncbi.nlm.nih.gov/pubmed/10868465

79 American diabetes Association et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27:596–601 http://www.diabetes.org/for-media/2004-press-releases/jan-27-04.jsp

80 Gill SS et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ330.7489 (2005): 445. http://www.bmj.com/content/330/7489/445.short

81 Gordon C et al. Do all relapses in schizophrenia warrant resumption of medication?. The American Journal of Psychiatry168.9 (2011): 987. PubMed ID: 21890806 http://www.ncbi.nlm.nih.gov/pubmed/21890806

82 Geddes JR et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet 2003;361:653–661. PubMed ID: 12606176 http://www.ncbi.nlm.nih.gov/pubmed/12606176

83 O’Neill C. Scientists reveal how electroconvulsive therapy can help depression. The Independent 20 March 2012. http://www.independent.co.uk/news/science/scientists-reveal-how-electroconvulsive-therapy-can-help-depression-7578294.html

84 Zorumski CF et al. Electroconvulsive therapy for the elderly: a review. Hospital & Community Psychiatry 39.6 (1988):643–647. PubMed ID: 3042587. http://www.ncbi.nlm.nih.gov/pubmed/3042587

85 van Beusekom BS et al. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study. The Journal of ECT 23.1 (2007):17–20. PubMed ID: 17435567. http://www.ncbi.nlm.nih.gov/pubmed/=1743556

86 Elkin I et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Archives of General Psychiatry 46.11 (1989):971–982. http://www.ncbi.nlm.nih.gov/pubmed/2684085

87 Conte HR et al. Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. JAMA Psychiatry 43.5 (1986): 471–479. PubMed ID: 3516110 http://archpsyc.jamanetwork.com/article.aspx?articleid=493803

88 Paykel ES. Psychotherapy, medication combination and compliance. Journal of Clinical Psychiatry 1995;56(suppl 1):24–30. http://www.ncbi.nlm.nih.gov/pubmed/7836348

89 Loonen AJ. Continuation and maintenance therapy with antidepressive agents: meta-analysis of research. Pharmaceutisch weekblad 13 (1991):167–175. PubMed ID: 1834986 http://www.ncbi.nlm.nih.gov/pubmed/1834986

90 Sternbach H. The serotonin syndrome. American Journal of Psychiatry 148 (1999):705–713. PubMed ID: 2035713 http://www.ncbi.nlm.nih.gov/pubmed/2035713

91 The Maudsely prescribing guidelines, 7th ed. London: Martin Dunitz; 2003 https://en.wikipedia.org/wiki/Maudsley_Prescribing_Guidelines

92 Stahl SM. Stahl’s essential psychpharmacology. Neuroscientific basis and practical applications, 2nd ed. Cambridge: Cambridge University Press; 2000 http://uk.cambridge.org/catalogue/catalogue.asp?isbn=0521646154

93 Larson EW et al. Organic causes of mania. Mayo Clinic Proceedings 63.9 (1988):906–912. http://www.ncbi.nlm.nih.gov/pubmed/3137394

94 Sproule B. Lithium in bipolar disorder: can drug concentrations predict therapeutic effect? Clinical Pharmacokinetics 41.9 (2002):639–660. PubMed ID: 12126457 http://www.ncbi.nlm.nih.gov/pubmed/12126457

95 Hawton K. Suicide risk and prevention in bipolar disorder. Psychiatr Danub 18 Suppl 1 (2006):33–34. http://www.ncbi.nlm.nih.gov/pubmed/16963886

96 Brown EB et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. Journal of Clinical Psychiatry 67.7 (2006):1025–1033. http://www.ncbi.nlm.nih.gov/pubmed/16889444

97 Schaffer A et al. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. Journal of Affective Disorders 96.1–2 (2006):95–99. PubMed ID: 16820213. http://www.ncbi.nlm.nih.gov/pubmed/16820213

98 Lieberman, Jeffrey A., et al. “Antipsychotic drug effects on brain morphology in first-episode psychosis.” Archives of General Psychiatry 62.4 (2005): 361–370. http://archpsyc.jamanetwork.com/article.aspx?articleid=208509&resultclick=1#Abstract

99 Cipriani A et al. Haloperidol alone or in combination for acute mania. Cochrane Database of Systematic Reviews 3 (2006):CD004362. PubMed ID: 16856043. http://www.ncbi.nlm.nih.gov/pubmed/16856043

100 Kramlinger et al. ADDing lithium carbonate to carbemazepine: antimanic efficacy in treatment resistant mania. Acta Psychiatrica Scandinavica 79 (1989):378–385. http://www.ncbi.nlm.nih.gov/pubmed/2500006

101 Miller DS et al. Comparitive efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Journal of Clinical Psychiatry 62 (2001):975–980. http://www.ncbi.nlm.nih.gov/pubmed/11780879

102 Tohen M et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry 59 (2002):62–69. http://archpsyc.ama-assn.org/cgi/content/abstract/57/9/841

103 Sachs GS. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgraduate Medicine Special Issue (2000):1–104. http://www.ncbi.nlm.nih.gov/pubmed/10895797

104 Compton MT. The treatment of bipolar depression. Journal of Clinical Psychiatry 2000;61 Suppl 9:57–67. http://www.ncbi.nlm.nih.gov/pubmed/10826663

105 Mukherjee S et al. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. American Journal of Psychiatry 1994;151:169–176. PubMed ID: 8296883 http://www.ncbi.nlm.nih.gov/pubmed/8296883

106 Sarris J et al. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Journal of Clinical Psychiatry 73.1 (2012):81–86. PubMed ID: 21903025 http://www.ncbi.nlm.nih.gov/m/pubmed/21903025/

107 Ferriman A. Levels of neurosis remained static in the 1990s. BMJ 323 (2001):130. http://www.ncbi.nlm.nih.gov/pubmed/11463676

108 Miller JJ et al. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. General Hospital Psychiatry 17.3 (1995):192–200. PubMed ID: 7649463 http://www.ncbi.nlm.nih.gov/pubmed/7649463

109 Linden M et al. Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study). Psychotherapy and Psychosomatics 2005; 74(1):36–42. PubMed ID: 15627855. http://www.ncbi.nlm.nih.gov/pubmed/15627855

110 Fisher PL. Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990. Psychological Medicine 29.6 (1999):1425–1434. http://www.ncbi.nlm.nih.gov/pubmed/10616949

111 Ashton C Jr. Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. Journal of Cardiovascular Surgery (Torino) 38.1 (1997):69–75. http://www.ncbi.nlm.nih.gov/pubmed/9128126

112 Rubio G et al. Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatrica Scandinavica 115.5 (2007):372–379. PubMed ID: 17430415. http://www.ncbi.nlm.nih.gov/pubmed/17430415

113 Ogai M et al. A right orbitofrontal region and OCD symptoms: a case report. Acta Psychiatr Scand 111.1 (2005):74–76. PubMed ID: 15636597. http://www.ncbi.nlm.nih.gov/pubmed/15636597

114 Ramsay R. Recent advances. Psychiatry. BMJ 311 (1995):167–170. http://www.ncbi.nlm.nih.gov/pubmed/7613431

115 OCD with schizophrenia overlap. 2005. http://www.schizophrenia.com/sznews/archives/002116.html

116 Furukawa TA et al. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews 1 (2007):CD004364. PubMed ID: 17253502. http://www.ncbi.nlm.nih.gov/pubmed/17253502

117 Baldwin D. Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group. British Journal of Psychiatry 175 (1999):120–126. http://www.ncbi.nlm.nih.gov/pubmed/10627793

118 Liebowitz MR. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depression and Anxiety 1999;10(3):89–98. http://www.ncbi.nlm.nih.gov/pubmed/10604081

119 Galea S. Psychological sequelae of the September 11 terrorist attacks in New York City. New England Journal of Medicine346.13 (2002):982–987. http://www.ncbi.nlm.nih.gov/pubmed/11919308

120 Villarreal G. Brain imaging in posttraumatic stress disorder. Seminars in Clinical Neuropsychiatry 6.2 (2001):131–145. http://www.ncbi.nlm.nih.gov/pubmed/11296313

121 Chatterjee P. Mental health care for India’s tsunami survivors. The Lancet 365 (2005): 833. PubMed ID: 15756722 http://www.ncbi.nlm.nih.gov/pubmed/15756722

122 The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Clinical Psychopharmacology 23.1 (2008):1–8. PubMed ID: 18090502. http://www.ncbi.nlm.nih.gov/pubmed/18090502

123 Stein DJ et al. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews 1 (2006):CD002795. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002795.pub2/abstract

124 NICE. Post-traumatic stress disorder: management (CG26). NIE; 2005 https://www.nice.org.uk/guidance/cg26

125 Simeon D. Feeling unreal: a PET study of depersonalization disorder. American Journal of Psychiatry 157.11 (2000):1782–1788. PubMed ID: 11058475 http://www.ncbi.nlm.nih.gov/pubmed/11058475

126 Radford B. Pokemon contagion: photosensitive epilepsy or mass psychogenic illness? Southern Medical Journal 94.2 (2001):197–204. PubMed ID: 11235034 http://www.ncbi.nlm.nih.gov/pubmed/11235034

127 Oakley DA. Hypnosis and conversion hysteria: a unifying model. Cognitive Neuropsychiatry 4.3 (1999):243–265. PubMed ID: 16571508. http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=16571508&from=cqsr

128 Greyson B. Dissociation in people who have near-death experiences: out of their bodies or out of their minds? The Lancet355 (2000):460–463. PubMed ID: 10841127. http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=10841127&from=cqsr

129 Anonymous. Antidepressant discontinuation syndrome:update on serotonin reuptake inhibitors. Journal of Clinical Psychiatry 1997;58(Suppl.7):3–40. No link available.

130 Lejoyeux M et al. Antidepressant withdrawal syndrome:recognition, prevention and management. CNS Drugs 5 (1996): 278–292. No link available.

131 Quitpaxil.org. (Personal experience blog.) http://www.quitpaxil.info/Main/advice.htm

132 Belloeuf L. Paroxetine withdrawal syndrome. Annales de Médecine Interne 151 Suppl A (2000):A52–53. http://www.ncbi.nlm.nih.gov/pubmed/10855379

133 Black K. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. Journal of Psychiatry & Neuroscience 25.3 (2000):255–61 http://www.ncbi.nlm.nih.gov/pubmed/10863885

134 Madox Ford F. The good soldier. London: Penguin; 1915. https://en.wikipedia.org/wiki/The_Good_Soldier

135 Hatcher S et al. Problem-solving therapy for people who present to hospital with self-harm: Zelen randomised controlled trial. The British Journal of Psychiatry 199.4 (2011): 310–316. http://bjp.rcpsych.org/content/199/4/310.short

136 Morell S et al. The decline in Australian young male suicide. Social Science and Medicine 64.3 (2007):747–754. PubMed ID: 17079062. http://www.ncbi.nlm.nih.gov/pubmed/17079062

137 Hawton K et al. Self-harm in England: a tale of three cities. Multicentre study of self-harm. Social Psychiatry and Psychiatric Epidemiology 42 (2007):513–521. http://www.ncbi.nlm.nih.gov/pubmed/17516016

138 Sylvia Plath Reads “A Birthday Present”: A Rare 1962 Recording. http://www.brainpickings.org/2012/10/29/sylvia-plath-reads-a-birthday-present-1962/

139 Joy CB. Crisis intervention for people with severe mental illnesses. Cochrane Database of Systematic Reviews 2 (2000):CD001087. http://www.ncbi.nlm.nih.gov/pubmed/10796414

140 Johnson S et al. Randomised controlled trial of acute mental health care by a crisis resolution team: the north Islington crisis study. BMJ 331 (2005):599–602. http://www.bmj.com/content/331/7517/599?goto=reply

141 Logullo F. Reversible combined cognitive impairment and severe polyneuropathy resulting from primary hyperparathyroidism. Italian Journal of Neurological Sciences 19.2 (1998):86–89. http://www.ncbi.nlm.nih.gov/pubmed/10935842

142 Jick H. Statins and the risk of dementia. Lancet 356 (2000):1627–1631. http://www.ncbi.nlm.nih.gov/pubmed/11089820

143 McCallum C et al. Sense of belonging and depressive symptoms among GLB adolescents. Journal of Homosexuality 58.1 (2010): 83–96. http://www.tandfonline.com/doi/abs/10.1080/00918369.2011.533629

144 Tracy K et al. Utilizing peer mentorship to engage high recidivism substance-abusing patients in treatment. The American Journal of Drug and Alcohol Abuse 37.6 (2011): 525–531. http://www.tandfonline.com/doi/abs/10.3109/00952990.2011.600385

145 Weeks GR. Toward a dialectical approach to intervention. Human Development 20.5 (1977): 277–292. http://www.karger.com/Article/FullText/271562

146 Michael KD. How effective are treatments for child and adolescent depression? A meta-analytic review. Clinical Psychology Review 22.2 (2002):247–269. PubMed ID: 11806021 http://www.ncbi.nlm.nih.gov/pubmed/11806021

147 Weeks GR. Toward a dialectical approach to intervention. Human Development 20.5 (1977): 277–292. http://www.karger.com/Article/FullText/271562

148 Ulloa RE et al. Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates. Journal of the American Academy of Child & Adolescent Psychiatry 39.3 (2000): 337–345. http://www.sciencedirect.com/science/article/pii/S0890856709661621

149 Erkwoh R et al. [Imperative auditory hallucinations in schizophrenia]. Fortschritte der Neurologie-Psychiatrie 69.5 (2001): 203–210. http://europepmc.org/abstract/med/11417259

150 Jenner JA et al. HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study. Acta Psychiatrica Scandinavica 103.2 (2001): 148–152. http://onlinelibrary.wiley.com/doi/10.1034/j.1600-0447.2001.00189.x/full

151 Hayden F. Long-term remission of schizophrenia in an adolescent treated with quetiapine. Journal of Child and Adolescent Psychopharmacology 11.3 (2001): 289–293. http://online.liebertpub.com/doi/abs/10.1089/10445460152595612

152 Nicolson R et al. Children and adolescents with psychotic disorder not otherwise specified: a 2-to 8-year follow-up study. Comprehensive Psychiatry 42.4 (2001): 319–325. http://www.sciencedirect.com/science/article/pii/S0010440X01626737

153 Fremont WP. School refusal in children and adolescents. American Family Physician 68.8 (2003): 1555–1568. http://assets.nysafp.org/docs/NYFD-Spring-2013-final.pdf#page=17

154 Bernstein GA et al. Treatment of school refusal: one-year follow-up. Journal of the American Academy of Child & Adolescent Psychiatry 40.2 (2001): 206–213. http://www.sciencedirect.com/science/article/pii/S0890856709603701

155 Galland BC et al. Mitchell. Helping children sleep. Archives of Disease in Childhood 95.10 (2010): 850–853. http://adc.bmj.com/content/95/10/850.short

156 Oldani A et al. Autosomal dominant nocturnal frontal lobe epilepsy. Brain 121 (1998): 205–223. http://brain.oxfordjournals.org/content/brain/121/2/205.full.pdf

157 Bahro M et al. [REM sleep parasomnia]. Der Nervenarzt 65.8 (1994): 568–571. http://europepmc.org/abstract/med/7969657

158 Boscolo-Berto R et al. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews 16.5 (2012): 431–443. http://www.sciencedirect.com/science/article/pii/S1087079211000967

159 McConachie H et al. Parent implemented early intervention for young children with autism spectrum disorder: A systematic review. Journal of Evaluation in Clinical Practice 13.1 (2007): 120–129. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2753.2006.00674.x/pdf

160 Szatmari P et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics 39.3 (2007): 319–328. http://www.nature.com/ng/journal/v39/n3/abs/ng1985.html

161 Goldacre B. Bad science. London: Fourth Estate; 2009. http://www.badscience.net/

162 Yoder P et al. Randomized comparison of two communication interventions for preschoolers with autism spectrum disorders. Journal of Consulting and Clinical Psychology 74.3 (2006):426–435. PubMed ID: 16822100. http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=16822100&from=cqsr

163 University of Southampton. Research reveals early intervention provides key to increased IQ in children with autism. 2007. http://www.southampton.ac.uk/news/2007/04/early-intervention-key-to-increased-iq.page

164 Elvins R et al. Pharmacological management of core and comorbid symptoms in autism-spectrum disorder. Advances in Psychiatric Treatment 16.5 (2010): 349–360. http://apt.rcpsych.org/content/16/5/349.short

165 Christison GW et al. Elimination diets in autism spectrum disorders: any wheat amidst the chaff? Journal of Developmental & Behavioral Pediatrics 27.2 (2006): S162–S171. http://journals.lww.com/jrnldbp/Abstract/2006/04002/Elimination_Diets_in_Autism_Spectrum_Disorders_.15.aspx

166 Faraone SV et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2.2 (2003): 104. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525089/

167 Aman MG et al. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology 14.2 (2004): 243–254. http://online.liebertpub.com/doi/abs/10.1089/1044546041649020

168 Lam LT. Attention deficit disorder and hospitalization owing to intra-and interpersonal violence among children and young adolescents. Journal of Adolescent Health 36.1 (2005): 19–24. http://www.sciencedirect.com/science/article/pii/S1054139X04001685

169 NICE. Attention deficit hyperactivity disorder (Clinical Guideline 72). NICE; 2008 http://www.nice.org.uk/CG72

170 Elia J et al. Treatment of attention-deficit–hyperactivity disorder. New England Journal of Medicine 340.10 (1999): 780–788. http://www.nejm.org/doi/full/10.1056/NEJM199903113401007

171 Schachter HM et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal 165.11 (2001): 1475–1488. http://www.cmaj.ca/content/165/11/1475.short

172 Office of National Statistics. UK government. http://www.ons.gov.uk/ons/index.html

173 The National Alcohol Harm Reduction Strategy. UK government. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/224075/alcohol-strategy.pdf

174 Kendler KS et al. Cocaine use, abuse and dependence in a population-based sample of female twins. The British Journal of Psychiatry 173.4 (1998): 345–350. http://bjp.rcpsych.org/content/173/4/345.short

175 World Health Organization. ICD-10 International Classification of Mental and Behavioural Disorders. http://www3.who.int/icd/vol1htm2003/fr-icd.htm

176 Harris KA et al. A 5-year evaluation of a methadone medical maintenance program. Journal of Substance Abuse Treatment 31.4 (2006): 433–438. http://www.sciencedirect.com/science/article/pii/S0740547206001607

177 Petrakis IL. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 95.2 (2000):219–228. PubMed ID: 10723850 http://www.ncbi.nlm.nih.gov/pubmed/10723850

178 Strang J et al. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials. American Journal on Addictions 8.4 (1999):337–348. http://www.ncbi.nlm.nih.gov/pubmed/10598217

179 Simoens S et al. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. British Journal of General Practice 55.511 (2005): 139–146. http://bjgp.org/content/55/511/139

180 Newbury-Birch D et al. Factors influencing alcohol and illicit drug use amongst medical students. Drug and Alcohol Dependence 59.2 (2000):125–130. http://www.ncbi.nlm.nih.gov/pubmed/10891625

181 Bartels C et al. Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol and Alcoholism 42.2 (2007): 92–102. http://www.researchgate.net/profile/Birgit_Kroener-Herwig/publication/6621396_Recovery_of_hippocampus-related_functions_in_chronic_alcoholics_during_monitored_long-term_abstinence/links/0a85e5383137a1161d000000.pdf

182 Morris PLP et al. Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 96.11 (2001): 1565–1573. http://www.ingentaconnect.com/content/carfax/cadd/2001/00000096/00000011/art00004

183 Annemans L et al. Economic evaluation of Campral®(acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. European Addiction Research 6.2 (2000): 71–78. http://www.karger.com/Article/FullText/19013

184 Kogawa M et al. [Osteoporosis and alcohol intake]. Clinical Calcium 15.1 (2005): 102–105. http://europepmc.org/abstract/med/15632479

185 Smith JE et al. The community reinforcement approach with homeless alcohol-dependent individuals. Journal of Consulting and Clinical Psychology 66.3 (1998): 541. http://psycnet.apa.org/journals/ccp/66/3/541/

186 Messent PR. Primary and secondary barriers to physically active healthy lifestyles for adults with learning disabilities. Disability and Rehabilitation 21.9 (1999):409–419. http://www.ncbi.nlm.nih.gov/pubmed/10548077

187 Mencap website. http://www.mencap.org.uk/

188 Durana IL et al. A comparison of procedures for decreasing public disrobing of an institutionalized profoundly mentally retarded woman. Mental Retardation 18. 4 (1980):185–188. PubMed ID: 7242354. http://www.ncbi.nlm.nih.gov/pubmed/7242354

189 Lindsay WR et al. The treatment of men with a learning disability convicted of exhibitionism. Research in Developmental Disabilities 19.4 (1998): 295–316. http://www.sciencedirect.com/science/article/pii/S0891422298000109

190 McNally RJ et al. Behavioral treatment of zoophilic exhibitionism. Journal of Behavior Therapy and Experimental Psychiatry 22.4 (1991):281–284. PubMed ID: 1823663. http://www.ncbi.nlm.nih.gov/pubmed/1823663

191 Clark LL et al. Learning disabilities within mental health services: are we adequately preparing nurses for the future? Journal of Psychiatric and Mental Health Nursing 14.5 (2007):433–437. PubMed ID: 17635250. http://www.ncbi.nlm.nih.gov/pubmed/17635250

192 Gortmaker VJ et al. Improving reading outcomes for children with learning disabilities: using brief experimental analysis to develop parent-tutoring interventions. Journal of Applied Behavior Analysis 40.2 (2007):203–221. PubMed ID: 176 24063. http://www.ncbi.nlm.nih.gov/pubmed/17624063

193 Investigation into the service for people with learning disabilities provided by Sutton and Merton Primary Care Trust. Healthcare Commission, 2007. http://tinyurl.com/pnq88da

194 Ziora K et al. [Anorexia nervosa in boys and men.] Wiad Lek 2006; 59(5–6):352–358. PubMed ID: 17017481. http://www.ncbi.nlm.nih.gov/pubmed/17017481

195 Rikani AA et al. A critique of the literature on etiology of eating disorders. Annals of Neurosciences 20.4 (2013): 157–161. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117136/

196 Forbush K et al. Relationships between perfectionism and specific disordered eating behaviors. International Journal of Eating Disorders 40.1 (2007):37–41. PubMed ID: 16958125. http://www.ncbi.nlm.nih.gov/pubmed/16958125

197 Ravaldi C et al. Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders. Psychopathology 36.5 (2003): 247–254. http://www.karger.com/Article/FullText/73450

198 Sayin A et al. [A male anorexia nervosa case and its discussion from dynamic point of view.] Turk Psikiyatri Derg 15.2 (2004):155–160. PubMed ID: 15208771. http://www.ncbi.nlm.nih.gov/pubmed/15208771

199 The British Psychological Society. Eating disorders: core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. http://www.bps.org.uk/eatingdisorders/files/ED.pdf

200 Millar HR et al. Anorexia nervosa mortality in Northeast Scotland, 1965–1999. American Journal of Psychiatry 162.4 (2005):753–757. PubMed ID: 15800149. http://www.ncbi.nlm.nih.gov/pubmed/15800149

201 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO; 1992 http://www.who.int/classifications/icd/en/

202 Mumford DB et al. Increased prevalence of bulimia nervosa among Asian schoolgirls. BMJ 297 (1988): 718. http://www.priory.com/psych/culture.htm

203 Carlat DJ et al. Eating disorders in males: a report on 135 patients. American Journal of Psychiatry 154.8 (1997):1127–1132. PubMed ID: 9247400. http://www.ncbi.nlm.nih.gov/pubmed/9247400

204 Royal College of Psychiatrists. Primary care protocols for common mental illnesses. Protocol III: Eating Disorders (18+years) identification and referral. Royal College of Psychiatrists. http://www.rcpsych.ac.uk/pdf/pcprotocol.pdf

205 Hay PJ et al. Psychotherapy for bulimia nervosa and binging. Cochrane Database of Systematic Reviews 3 (2004):CD000562. PubMed ID: 15266434 http://www.ncbi.nlm.nih.gov/pubmed/15266434

206 Hsu LK. Outcome of bulimia nervosa. In Brownell KD (eds) Eating disorders and obesity. New York: Guildford Press; 1995, 238–246. http://www.guilford.com/cgi-bin/search.cgi?type=dir&pattern=pp/ed&cart_id=264841.8102

207 Kleinplatz PJ. Coming out of the sex therapy closet: using experiential psychotherapy with sexual problems and concerns. American Journal of Psychotherapy 61 (2007): 333–348. PubMed ID: 17985534. http://www.ncbi.nlm.nih.gov/pubmed/17985534

208 Crepault C et al. Men’s erotic fantasies. Archives of Sexual Behavior 9.6 (1980): 565–581. http://link.springer.com/article/10.1007/BF01542159

209 Melnik T et al. Psychosocial interventions for erectile dysfunction. Cochrane Database of Systematic Reviews 3 (2007):CD004825. PubMed ID: 17636774 http://www.ncbi.nlm.nih.gov/pubmed/17636774

210 McFarlane J et al. Intimate partner sexual assault against women: frequency, health consequences, and treatment outcomes. Obstetrics and Gynecology 105.1 (2005):99–108. PubMed ID: 15625149. http://www.ncbi.nlm.nih.gov/pubmed/15625149

211 DeJong J. Reproductive health of Arab young people. BMJ 333 (2006):849–851. http://bmj.bmjjournals.com/cgi/content/full/333/7573/849

212 Russell, ST et al. Adolescent sexual orientation and suicide risk: Evidence from a national study. American Journal of Public Health 91.8 (2001): 1276–1281. http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.91.8.1276

213 Boyd M. Lucinda Brayford. 1952 http://www.middlemiss.org/lit/authors/boydm/lbrayford.html

214 Families and Friends of Lesbians and Gays (FFLAG) website. http://www.fflag.org.uk/

215 Pollack R and Schwartz C in their book, The Journey Out - A guide for and about lesbian, gay, and bisexual teens. New York: Puffin; 1995. http://www.chebucto.ns.ca/Health/TeenHealth/SexOrien/gay.html

216 Troth A et al. Factors predicting safe-sex talk and condom use in early sexual relationships. Health Communication2000;12(2):195–218. http://www.ncbi.nlm.nih.gov/pubmed/10938913

217 London addresses: Family Planning: 2 Pentonville Rd, N1 9FP 0207 837 4044; Brook Centre: 165 Grays Inn Rd, WC1X 8UD; 0207 713 9000. Sex Education Forum: 8 Wakley Street, EC1V 7QE; Contraceptive Education Service 0207 837 4044.

218 Wisner KL et al. Clinical practice. Postpartum depression. New England Journal of Medicine 347 (2002):194–199. PubMed ID: 12124409 http://www.ncbi.nlm.nih.gov/pubmed/12124409

219 Beck CT. The effects of postpartum depression on child development: a meta-analysis. Archives of Psychiatric Nursing12.1 (1998):12–20. http://www.ncbi.nlm.nih.gov/pubmed/9489170

220 Cummings EM. Maternal depression and child development. Journal of Child Psychology and Psychiatry 35.1 (1994):73–112. http://www.ncbi.nlm.nih.gov/pubmed/8163630

221 McHug B. Fathers and postnatal depression. Families.com. http://mental-health.families.com/blog/fathers-and-postnatal-depression

222 Grube M. [Peripartum psychiatric disorders--support through men? A first approach]. Der Nervenarzt 75.5 (2004): 483–488. http://europepmc.org/abstract/med/15252889

223 Cox JL et al. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 150 (1987): 782–786. PubMed ID: 3651732. http://www.ncbi.nlm.nih.gov/pubmed/3651732

224 Westen D et al. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychological Bulletin 130.4 (2004):631–663. PubMed ID: 15250817. http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=15250817&from=cqsr

225 Weisz JR et al. Jousting with straw men: comment on Westen, Novotny, and Thompson-Brenner (2004). Psychological Bulletin 131.3 (2005):418–426, discussion 427–433. PubMed ID: 15869338. http://www.ncbi.nlm.nih.gov/pubmed/15869338

226 Williams C et al. A cognitive behavioural therapy assessment model for use in everyday clinical practice. Advances in Psychiatr Treatment 8 (2002):172–179 http://apt.rcpsych.org/cgi/content/full/8/3/172

227 Plaud JJ. Pavlov and the foundation of behavior therapy. Spanish Journal of Psychology 6.2 (2003):147–154. PubMed ID: 14628701. http://www.ncbi.nlm.nih.gov/pubmed/14628701

228 Harris CV et al. An analysis of response prevention and flooding procedures in the treatment of adolescent obsessive compulsive disorder. Journal of Behavior Therapy and Experimental Psychiatry 23.2 (1992):107–15. PubMed ID: 1360985. http://www.ncbi.nlm.nih.gov/pubmed/1360985

229 Granado LC et al. A spiderless arachnophobia therapy: comparison between placebo and treatment groups and six-month follow-up study. Neural Plasticity 2007 (2007):10241. PubMed ID: 17713595 http://www.ncbi.nlm.nih.gov/pubmed/17713595

230 Vaillant GE. Ego mechanisms of defense. A guide for clinicians and researchers. Washington, DC: APA. ISBN 0-88048-404-7. http://www.appi.org/index.cfm

231 Pope KS et al. Sexual attraction to clients: the human therapist and the (sometimes) inhuman training system. American Psychologist 41.2 (1986):147–158. http://kspope.com/sexiss/research5.php

232 Equus is a play by Peter Shaffer (1973) about a psychiatrist who attempts to treat a young man who has a religious/sexual fascination with horses. http://en.wikipedia.org/wiki/Equus_%28play%29#Plot_summary

233 Molenaar PJ et al. Is there a dose-effect relationship between the number of psychotherapy sessions and improvement of social functioning? British Journal of Clinical Psychology 50.3 (2011):268–282. PubMed ID: 21810106 http://www.ncbi.nlm.nih.gov/pubmed/21810106/

234 Salvador Minuchin biography. https://en.wikipedia.org/wiki/Salvador_Minuchin

235 Epstein N. Problem-centred systems therapy. In Gurman AS (ed) Handbook of family therapy. New York, Brunner/Mazel; 1981. https://books.google.co.uk/books/about/Handbook_of_Family_Therapy.html?id=rs-2SAAACAAJ

236 Klar H. Brief solution-focused strategies for behavioral pediatrics. Pediatric Clinics of North America 42.1 (1995):131–141. http://www.ncbi.nlm.nih.gov:/pubmed7854868

237 Bower P. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. BMJ 321 (2000):1389–1392. http://www.ncbi.nlm.nih.gov/pubmed/=11099285

238 Ward E. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness. BMJ 321 (2000):1383–1388. http://www.ncbi.nlm.nih.gov/pubmed/11099284

239 Tylee A. Counselling in primary care. The Lancet 350 (1997):1643. http://www.ncbi.nlm.nih.gov/pubmed/9400503

240 De Shazer S. Keys to solution in brief therapy. New York: Norton; 1985. https://books.google.co.uk/books/about/Keys_to_Solution_in_Brief_Therapy.html?id=EnmAQgAACAAJ

241 Lancaster T. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2 (2000):CD001292. http://www.ncbi.nlm.nih.gov/pubmed/10796638

242 Fukui S. A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer 89.5 (2000):1026–1036. http://www.ncbi.nlm.nih.gov/pubmed/10964333

243 Smith LA et al. Therapeutic communities for substance related disorder. Cochrane Database of Systematic Reviews 1 (2006):CD005338. PubMed ID: 16437526. http://www.ncbi.nlm.nih.gov/pubmed/16437526

244 Perry A et al. Interventions for drug-using offenders in the courts, secure establishments and the community. Cochrane Database of Systematic Reviews 3 (2006):CD005193. PubMed ID: 16856083. http://www.ncbi.nlm.nih.gov/pubmed/16856083

245 Broekaert E et al. The third generation of therapeutic communities: the early development of the TC for addictions in Europe. European Addiction Research 2006; 12(1):1–11. PubMed ID: 16352897. http://www.ncbi.nlm.nih.gov/pubmed/16352897

246 Joyce A. Insight and the nature of therapeutic action in the psychoanalysis of 4- and 5-year-old children. International Journal of Psychoanalysis 81 Pt 6 (2000):1139–1154. http://www.ncbi.nlm.nih.gov/pubmed/11144854

247 Bratton S et al. The efficacy of play therapy with children: a meta-analytic review of treatment outcomes. Professional Psychology: Research and Practice 36.4 (2005):376–390. http://psycnet.apa.org/journals/pro/36/4/376/

248 Bolton P et al. Interventions for depression symptoms among adolescent survivors of war and displacement in northern Uganda: a randomized controlled trial. JAMA 298.5 (2007):519–527. PubMed ID: 1766667 http://www.ncbi.nlm.nih.gov/pubmed/17666672

249 Hetzel-Riggin MD et al. A meta-analytic investigation of therapy modality outcomes for sexually abused children and adolescents: an exploratory study. Child Abuse & Neglect 31.2 (2007):125–141. PubMed ID: 17306369 http://www.ncbi.nlm.nih.gov/pubmed/17306369

250 Allin H et al. Treatment of child neglect: a systematic review. Canadian Journal of Psychiatry 50.8 (2005):497–504. PubMed ID: 16127968 http://www.ncbi.nlm.nih.gov/pubmed/16127968

251 Legoff DB et al. Long-term outcome of social skills intervention based on interactive LEGO play. Autism 10.4 (2006):317–329. PubMed ID: 16908476. http://www.ncbi.nlm.nih.gov/pubmed/16908476

252 Keeling ML et al. Externalizing problems through art and writing: Experience of process and helpfulness. Journal of Marital and Family Therapy 32.4 (2006): 405–419. http://onlinelibrary.wiley.com/doi/10.1111/j.1752-0606.2006.tb01617.x/abstract

253 Massimo LM et al. In Tribute to Luigi Castagnetta—Drawings. Annals of the New York Academy of Sciences 1089.1 (2006): xvi–xxiii. http://www.ncbi.nlm.nih.gov/pubmed/17342818

254 Ahmed SH et al. Essay: healing through art therapy in disaster settings. The Lancet 368 (2006): S28–S29. http://www.thelancet.com/journals/lancet/article/PIIS0140673606699169/abstract

255 Schmitt B et al. [Creative therapy options for patients with dementia--a systematic review]. Fortschritte der Neurologie-Psychiatrie 75.12 (2007): 699–707. http://europepmc.org/abstract/med/17443437

256 The management of patients with physical and psychological problems in primary care: a practical guide Report of a joint working group of the Royal College of General Practitioners and the Royal College of Psychiatrists http://www.rcpsych.ac.uk/files/pdfversion/CR152x.pdf

257 Öster Inger RNT et al. Art therapy improves coping resources: a randomized, controlled study among women with breast cancer. Palliative & Supportive Care 4.01 (2006): 57–64. http://journals.cambridge.org/abstract_S147895150606007X

258 Top 10 Art Therapy Myths on Art Therapy Spot blog http://arttherapyspot.com/2011/02/21/top-10-art-therapy-myths/

259 Medical Protection Society. Capacity (Competence) and capacity. MPS; 2014 http://www.medicalprotection.org/uk/advice-booklets/mps-guide-to-ethics---a-map-for-the-moral-maze/chapter-8---patient-autonomy-and-consent/capacity-(competence)

260 Jeste DV et al. Multimedia educational aids for improving consumer knowledge about illness management and treatment decisions: a review of randomized controlled trials. Journal of Psychiatric Research 42.1 (2008): 1–21. http://www.sciencedirect.com/science/article/pii/S002239560600210X

261 Feldman E. The Mental Health Act and Common Law. In Peveler R et al. (eds) Liaison Psychiatry: Planning services for specialist settings. London: Gaskell; 2000. http://www.rcpsych.ac.uk/college/faculty/liaison/traincon/revPsss.htm


[Regresar]